Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Clinical prospective study of Gallium 68 (68Ga)-labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma.
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2152-2166. doi: 10.1007/s00259-023-06137-z. Epub 2023 Feb 21.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36809426
Correction to: Clinical prospective study of Gallium 68 (68Ga)-labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma.
Jinghua L, Kui X, Deliang G, Bo L, Qian Z, Haitao W, Yaqun J, Dongde W, Xigang X, Ping J, Shengli T, Zhiyong Y, Yueming H, Zhonglin Z, Yong H, Yufeng Y.
Jinghua L, et al. Among authors: zhonglin z.
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2230. doi: 10.1007/s00259-023-06188-2.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36929212
No abstract available.
Item in Clipboard
Cite
Cite